B-type natriuretic Peptide and the right heart

Area of Science:

• Cardiology
• Pulmonology
• Biomarkers

Background:

• Ventricular volume and pressure overload elevate B-type natriuretic peptide (BNP).
• Right ventricular (RV) dysfunction and pulmonary arterial hypertension (PAH) are significant clinical conditions.
• BNP plays a crucial role in the pathophysiology and clinical management of these conditions.

Purpose of the Study:

• To review the physiological, diagnostic, and therapeutic roles of BNP in RV dysfunction and PAH.
• To explore the utility of BNP in differentiating respiratory disease from PAH in breathless patients.
• To assess the potential of BNP-guided therapy in PAH.

Main Methods:

• Review of existing literature on BNP in RV dysfunction and PAH.
• Analysis of correlations between BNP levels, mean pulmonary arterial pressure, and pulmonary vascular resistance.
• Evaluation of BNP as a predictor of mortality in primary pulmonary hypertension.

Main Results:

• BNP levels differentiate respiratory disease from PAH.
• BNP correlates with hemodynamic parameters (mean pulmonary arterial pressure, pulmonary vascular resistance) in PAH.
• BNP predicts mortality in primary pulmonary hypertension.
• BNP and NT-proBNP may guide therapeutic decisions, including the use of pulmonary vasorelaxants.

Conclusions:

• BNP is a valuable non-invasive biomarker for diagnosing and assessing the severity of PAH.
• BNP measurements can guide therapeutic interventions and identify patients needing further invasive procedures.
• Enhancing the natriuretic peptide pathway holds therapeutic potential for RV dysfunction and PAH.